JASON MENGES: Open Payments
NPI 1982691242 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,372 in 193 payments from 36 companies in 2025. Trend: 2023 $2,621 · 2024 $2,950 · 2025 $3,372
Food & beverage: $3,197Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $440 |
| Xeris Pharmaceuticals, Inc. | 18 | $296 |
| Insulet Corporation | 38 | $250 |
| Abbott Laboratories | 7 | $239 |
| Novo Nordisk Inc | 17 | $191 |
| RECORDATI_RARE_DISEASES_INC. | 8 | $191 |
| Lilly USA, LLC | 11 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $151 |
| Medtronic, Inc. | 6 | $151 |
| Dexcom, Inc. | 5 | $120 |
Products named: Omnipod, FREESTYLE LIBRE 3, ISTURISA, MOUNJARO, PROLIA, RECORLEV, Kerendia, GVOKE HYPOPEN.
Industry payments across KS — which companies pay providers there.
